RU2010129474A - PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ULCER OF THE STOMACH AND / OR 12 DIGITAL GUT - Google Patents

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ULCER OF THE STOMACH AND / OR 12 DIGITAL GUT Download PDF

Info

Publication number
RU2010129474A
RU2010129474A RU2010129474/15A RU2010129474A RU2010129474A RU 2010129474 A RU2010129474 A RU 2010129474A RU 2010129474/15 A RU2010129474/15 A RU 2010129474/15A RU 2010129474 A RU2010129474 A RU 2010129474A RU 2010129474 A RU2010129474 A RU 2010129474A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
ppi
composition according
proton pump
pump inhibitor
Prior art date
Application number
RU2010129474/15A
Other languages
Russian (ru)
Other versions
RU2448702C2 (en
Inventor
Роман Йонович Максвитис (RU)
Роман Йонович Максвитис
Роман Владимирович Иванов (RU)
Роман Владимирович Иванов
Александр Анатольевич Донецкий (RU)
Александр Анатольевич Донецкий
Original Assignee
Общество с ограниченной ответственностью "ЭР ЭНД ДИ ФАРМА" (RU)
Общество с ограниченной ответственностью "ЭР ЭНД ДИ ФАРМА"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "ЭР ЭНД ДИ ФАРМА" (RU), Общество с ограниченной ответственностью "ЭР ЭНД ДИ ФАРМА" filed Critical Общество с ограниченной ответственностью "ЭР ЭНД ДИ ФАРМА" (RU)
Priority to RU2010129474/15A priority Critical patent/RU2448702C2/en
Publication of RU2010129474A publication Critical patent/RU2010129474A/en
Application granted granted Critical
Publication of RU2448702C2 publication Critical patent/RU2448702C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1. Фармацевтическая композиция для лечения язвенной болезни желудка и/или 12-перстной кишки содержащее ингибитор протонной помпы (ИПП), отличающаяся тем, что дополнительно содержит N-ацетил-5-метокситриптамин (мелатонин) в следующем соотношении компонентов: ! ингибитор протонной помпы (ИПП) 10-30 мг N-ацетил-5-метокситриптамин (мелатонин) 2 - 8 мг вспомогательные вещества до 100 мг ! 2. Фармацевтическая композиция по п.1, отличающаяся тем, что ингибитором протонной помпы (ИПП) может являться одно из соединений: лансопразол, омепразол, рабепразол, эзомепразол, пантопразол. ! 3. Фармацевтическая композиция по п.1, отличающаяся тем, что твердая лекарственная форма (таблетки, таблетки покрытые оболочкой, мягкие желатиновые капсулы, твердые желатиновые капсулы). ! 4. Фармацевтическая композиция по п.1, отличающаяся тем, что мягкая лекарственная форма (суппозитории ректальные). 1. A pharmaceutical composition for the treatment of gastric ulcer and / or duodenal ulcer containing a proton pump inhibitor (PPI), characterized in that it further comprises N-acetyl-5-methoxytryptamine (melatonin) in the following ratio:! proton pump inhibitor (PPI) 10-30 mg N-acetyl-5-methoxytryptamine (melatonin) 2 - 8 mg excipients up to 100 mg! 2. The pharmaceutical composition according to claim 1, characterized in that the proton pump inhibitor (PPI) can be one of the compounds: lansoprazole, omeprazole, rabeprazole, esomeprazole, pantoprazole. ! 3. The pharmaceutical composition according to claim 1, characterized in that the solid dosage form (tablets, coated tablets, soft gelatin capsules, hard gelatin capsules). ! 4. The pharmaceutical composition according to claim 1, characterized in that the soft dosage form (rectal suppositories).

Claims (4)

1. Фармацевтическая композиция для лечения язвенной болезни желудка и/или 12-перстной кишки содержащее ингибитор протонной помпы (ИПП), отличающаяся тем, что дополнительно содержит N-ацетил-5-метокситриптамин (мелатонин) в следующем соотношении компонентов:1. A pharmaceutical composition for the treatment of gastric ulcer and / or duodenal ulcer containing a proton pump inhibitor (PPI), characterized in that it further comprises N-acetyl-5-methoxytryptamine (melatonin) in the following ratio of components: ингибитор протонной помпы (ИПП)proton pump inhibitor (PPI) 10-30 мг10-30 mg N-ацетил-5-метокситриптамин (мелатонин)N-acetyl-5-methoxytryptamine (melatonin) 2 - 8 мг2 - 8 mg вспомогательные веществаExcipients до 100 мгup to 100 mg
2. Фармацевтическая композиция по п.1, отличающаяся тем, что ингибитором протонной помпы (ИПП) может являться одно из соединений: лансопразол, омепразол, рабепразол, эзомепразол, пантопразол.2. The pharmaceutical composition according to claim 1, characterized in that the proton pump inhibitor (PPI) can be one of the compounds: lansoprazole, omeprazole, rabeprazole, esomeprazole, pantoprazole. 3. Фармацевтическая композиция по п.1, отличающаяся тем, что твердая лекарственная форма (таблетки, таблетки покрытые оболочкой, мягкие желатиновые капсулы, твердые желатиновые капсулы).3. The pharmaceutical composition according to claim 1, characterized in that the solid dosage form (tablets, coated tablets, soft gelatin capsules, hard gelatin capsules). 4. Фармацевтическая композиция по п.1, отличающаяся тем, что мягкая лекарственная форма (суппозитории ректальные). 4. The pharmaceutical composition according to claim 1, characterized in that the soft dosage form (rectal suppositories).
RU2010129474/15A 2010-07-16 2010-07-16 Pharmaceutical composition for gastric and/or duodenal ulcer RU2448702C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2010129474/15A RU2448702C2 (en) 2010-07-16 2010-07-16 Pharmaceutical composition for gastric and/or duodenal ulcer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2010129474/15A RU2448702C2 (en) 2010-07-16 2010-07-16 Pharmaceutical composition for gastric and/or duodenal ulcer

Publications (2)

Publication Number Publication Date
RU2010129474A true RU2010129474A (en) 2012-01-27
RU2448702C2 RU2448702C2 (en) 2012-04-27

Family

ID=45786095

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010129474/15A RU2448702C2 (en) 2010-07-16 2010-07-16 Pharmaceutical composition for gastric and/or duodenal ulcer

Country Status (1)

Country Link
RU (1) RU2448702C2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0312419D0 (en) * 2003-05-30 2003-07-02 Boots Healthcare Int Ltd Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
CN1814291A (en) * 2005-12-09 2006-08-09 济南康泉医药科技有限公司 Medicine composition for preventing and treating degestive ulcer

Also Published As

Publication number Publication date
RU2448702C2 (en) 2012-04-27

Similar Documents

Publication Publication Date Title
Shi et al. Proton pump inhibitors: an update of their clinical use and pharmacokinetics
Lee et al. Randomised phase 3 trial: tegoprazan, a novel potassium‐competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis
MY193257A (en) Novel 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same
RU2007140941A (en) Compositions and methods of suppressing the secretion of the gastric juice
WO2009017716A3 (en) Pulsatile gastric retentive dosage forms
ES2509117T3 (en) Oral pharmaceutical composition containing dabigatran etexilate
AR078038A1 (en) TOBACCO TREATED
RU2015138708A (en) PHARMACEUTICAL COMPOSITIONS FOR TREATMENT FROM HELICOBACTER PYLORI
RU2015104537A (en) METHODS FOR TREATING STOMAL TUMORS OF THE GASTROINTESTINAL TRACT
MX2010010647A (en) Process for preparing orally administered dabigatran formulations.
AU2011337549A1 (en) Orally disintegrating tablet
RU2009111362A (en) PHARMACEUTICAL COMPOSITION OF A PROTON PUMP INHIBITOR AND PREBIOTIC FOR TREATMENT OF ULCER OF THE STOMACH AND 12-FINGER GUT
RU2007141655A (en) COMBINED USE OF PROSTAGLANDINE DERIVATIVE AND PROTON PUMP INHIBITOR FOR TREATMENT OF GASTROINTESTINAL DISEASES
ATE512969T1 (en) BENZIMIDAZOLE DERIVATIVES AS SELECTIVE ACID PUMP INHIBITORS
Xia et al. Gastroesophageal Reflux Disease Relief in Patients Treated with Rabeprazole 20 mg versus Omeprazole 20 mg: A Meta‐Analysis
JP2016508516A5 (en)
EA200601901A1 (en) COMPOSITIONS CONTAINING IMMUNE MODULATING COMPOUNDS FOR THE TREATMENT AND MANAGEMENT OF THE COURSE OF MYELODYLASTIC SYNDROME AND METHODS USING
RU2007132704A (en) ORGANIC COMPOUNDS
RU2014118490A (en) TREATMENT OF PHARMACOLOGICALLY INDUCED HYPOCHLORHYDRIA
RU2016136351A (en) PYRROL-SUBSTITUTED INDOLONE DERIVATIVE, METHOD OF ITS PRODUCTION INCLUDING ITS COMPOSITION AND APPLICATION
Thitiphuree et al. Esomeprazole, a new proton pump inhibitor: pharmacological characteristics and clinical efficacy
RU2010129474A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ULCER OF THE STOMACH AND / OR 12 DIGITAL GUT
AU2004237362A1 (en) Proton pump inhibitors for the treatment of lower abdominal disorders
RU2009106450A (en) COMPOSITIONS AND METHODS FOR INHIBITING GASTRIC ACID SECRETION USING DERIVATIVES OF SMALL DICARBOXYLIC ACIDS IN COMBINATION WITH PPI
CA2648538A1 (en) Oral rapid release pharmaceutical formulation for pyridylmethylsulfinyl-benzimidazoles

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20130717

NF4A Reinstatement of patent

Effective date: 20160110

MM4A The patent is invalid due to non-payment of fees

Effective date: 20170717

NF4A Reinstatement of patent

Effective date: 20190212

MM4A The patent is invalid due to non-payment of fees

Effective date: 20200717